UNH Valuation

UnitedHealth Group Inc

Add to Watchlist

Advanced Chart

281.060

+2.48(0.890%)1D

Overview
Forecast
Valuation
Earnings

UNH Relative Valuation

UNH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, UNH is overvalued; if below, it's undervalued.

Historical Valuation

UnitedHealth Group Inc (UNH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 13.62 is considered Undervalued compared with the five-year average of 19.83. The fair price of UnitedHealth Group Inc (UNH) is between 338.20 to 412.60 according to relative valuation methord. Compared to the current price of 281.06 USD , UnitedHealth Group Inc is Undervalued By 16.9%.

Relative Value

Fair Zone

338.20-412.60

Current Price：281.06

16.9%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.69

P/B

Median3y

5.48

Median5y

5.55

9.84

FCF Yield

Median3y

5.10

Median5y

5.23

Competitors Valuation Multiple

The average P/S ratio for UNH's competitors is 0.33, providing a benchmark for relative valuation. UnitedHealth Group Inc Corp (UNH) exhibits a P/S ratio of 0.55, which is 65.62% above the industry average. Given its robust revenue growth of 9.80%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

UNH.N

UnitedHealth Group Inc

0.55

Average P/S: 0.33

9.80%